[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.41.181. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 1985

Penetration of Topical Cyclosporine Into the Rabbit Cornea, Aqueous Humor, and Serum

Author Affiliations

From the Lions Eye Research Laboratories, LSU Eye Center, Louisiana State University Medical Center School of Medicine, New Orleans.

Arch Ophthalmol. 1985;103(1):101-102. doi:10.1001/archopht.1985.01050010107030
Abstract

• Systemic and ocular absorption of topically applied 10% cyclosporine ointment was determined in rabbit cornea, aqueous humor, and serum by radioimmunoassay. The concentration of the drug in the cornea reached a peak of 900 ng/mL three hours after application. Substantial levels were still present at 24 hours. Relatively low concentrations were measured in the aqueous humor and serum, suggesting corneal stromal pooling of this hydrophobic cyclic peptide. Topical ocular application of cyclosporine may reduce or eliminate the drug's systemic toxic effects while maintaining a therapeutic level of local immunosuppressive activity.

References
1.
Borel JF:  Cyclosporin-A: Present experimental status . Transplant Proc 1981;13:344-348.
2.
Leapman SB, Filo RS, Smith EJ, et al:  Differential effects of cyclosporin-A on lymphocyte subpopulation . Transplant Proc 1981;13:405-409.
3.
Calne RY, Rolles K, White DJG, et al:  Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: Thirty-two kidneys, two pancreases, and two livers . Lancet 1979;2:1033-1036.Article
4.
Palacios R, Möller G:  Cyclosporin A blocks receptors for HLA-DR antigens on T cells . Nature 1981;290:792-796.Article
5.
Calne RY, Rolles K, White DJG, et al:  Cyclosporin A in clinical organ grafting . Transplant Proc 1981;13:349-358.
6.
Nussenblatt RB, Palestine MD, Chan CC:  Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents . Am J Ophthalmol 1983;96:275-282.
7.
Hunter PA, Garner A, Wilhelmus KR, et al:  Corneal graft rejections: A new rabbit model and cyclosporin-A . Br J Ophthalmol 1982;66:292-302.Article
8.
Kana JS, Hoffmann F, Buchen R, et al:  Rabbit corneal allograft survival following topical administration of cyclosporin A . Invest Ophthalmol Vis Sci 1982;22:686-690.
9.
Salisbury JD, Gebhardt BM:  Suppression of corneal allograft rejection by cyclosporin A . Arch Ophthalmol 1981;99:1640-1643.Article
10.
Bell TAG, Easty DL, McCullagh KG:  A placebo-controlled blind trial of cyclosporin A in prevention of corneal graft rejections in rabbits . Br J Ophthalmol 1982;66:303-308.Article
11.
Donatsch P, Abisch E, Homberger M, et al:  A radioimmunoassay to measure cyclosporin A in plasma and serum samples . J Immunoassay 1981;2:19-32.Article
12.
Cyclosporin RIA-Kit . Basel, Switzerland, Sandoz Ltd, 1983.
13.
Havener WH: Ocular Pharmacology , ed 3. St Louis, CV Mosby Co, 1974.
14.
Calne RY, White PJG:  The use of cyclosporin A in clinical organ grafting . Ann Surg 1982;9:330-337.Article
×